UNSPSC 51451911: Piperamide maleate

This classification denotes an antihelminthic agent with the molecular formula C17H28N4O.2C4H4O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7T952LZM7T, chemically known as acetanilide, 4-(4-(3-(dimethylamino)propyl)-1-piperazinyl)-, maleate (1:2) but more generally known as piperamide maleate, which bears US NIH Compound Identifier 6433263. Most nations, for tariff and trade purposes, schedule piperamide maleate under HS 29335995 and SITC 51576. As of Q4 2014, PIPERAMIDE MALEATE remains US FDA's Preferred Term for this commodity.

Piperamide maleate bears US NLM identifiers UMLS ID C1882385 and NCI Concept Code C66397. SMILES: CC(=O)NC1CCC(CC1)N2CCN(CC2)CCCN(C)C.C(=C\C(=O)O)\C(=O)O.C(=C\C(=O)O)\C(=O)O.

UNSPSC 51451911 Piperamide maleate is a Commodity code that nominally describes a single pharmaceutical compound, but recent state and local procurement activity under this code shows minimal alignment with the code's stated scope. The two most recent opportunities tagged to this code involve naloxone (an opioid antagonist) and antibiotic tablets (doxycycline and ciprofloxacin), neither of which is piperamide maleate. Issuing bodies using this code include state health departments and county governments; the Illinois Department of Public Health and Seminole County, Florida both appear in recent records. The actual procurement pattern reflects broader pharmaceutical supply and emergency-preparedness purchases rather than a single active pharmaceutical ingredient.

Geographic activity is concentrated in Illinois and Florida based on the recent record. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for doxycycline hyclate and ciprofloxacin hydrochloride, totaling $2,999,999.11 over a 12-month initial term with two renewal options; this was a completed award under an Invitation for Bid process, not an open solicitation. Seminole County, Florida posted an IFB (Solicitation Number IFB60459723LAS) on June 30, 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually, with quarterly deliveries to the Seminole County Community Health Building in Sanford and a response deadline of July 26, 2023. The mismatch between the code's pharmaceutical chemical scope and the substance of these opportunities suggests this code may be incorrectly applied to these procurements, or the code's actual usage in state and local systems diverges significantly from its UNSPSC definition.